The latest closing stock price for CNS Pharmaceuticals as of September 18, 2024 is 0.16.
An investor who bought $1,000 worth of CNS Pharmaceuticals stock at the IPO in 2019 would have $-1,000 today, roughly -1 times their original investment - a -88.15% compound annual growth rate over 5 years.
The all-time high CNS Pharmaceuticals stock closing price was 7485.00 on January 10, 2020.
The CNS Pharmaceuticals 52-week high stock price is 137.50, which is 85837.5% above the current share price.
The CNS Pharmaceuticals 52-week low stock price is 0.10, which is 37.5% below the current share price.
The average CNS Pharmaceuticals stock price for the last 52 weeks is 31.67.
An investor who bought $1,000 worth of CNS Pharmaceuticals stock at the IPO in 2019 would have $-1,000 today, roughly -1 times their original investment - a -88.15% compound annual growth rate over 5 years.
The all-time high CNS Pharmaceuticals stock closing price was 7485.00 on January 10, 2020.
The CNS Pharmaceuticals 52-week high stock price is 137.50, which is 85837.5% above the current share price.
The CNS Pharmaceuticals 52-week low stock price is 0.10, which is 37.5% below the current share price.
The average CNS Pharmaceuticals stock price for the last 52 weeks is 31.67.